Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Childhood Overweight, Tallness, and Growth Increase Risks of Ovarian Cancer.

Aarestrup J, Trabert B, Ulrich LG, Wentzensen N, Sørensen TIA, Baker JL.

Cancer Epidemiol Biomarkers Prev. 2019 Jan;28(1):183-188. doi: 10.1158/1055-9965.EPI-18-0024. Epub 2018 Sep 27.

PMID:
30262600
2.

Birth weight and the risk of histological subtypes of ovarian and endometrial cancers: Results from the Copenhagen School Health Records Register.

Trabert B, Aarestrup J, Ulrich LG, Wentzensen N, Sørensen TIA, Baker JL.

Gynecol Oncol. 2018 Mar;148(3):547-552. doi: 10.1016/j.ygyno.2017.12.031. Epub 2018 Jan 11.

3.

Childhood body mass index growth trajectories and endometrial cancer risk.

Aarestrup J, Gamborg M, Tilling K, Ulrich LG, Sørensen TI, Baker JL.

Int J Cancer. 2017 Jan 15;140(2):310-315. doi: 10.1002/ijc.30464. Epub 2016 Oct 26.

4.

Childhood body mass index and height and risk of histologic subtypes of endometrial cancer.

Aarestrup J, Gamborg M, Ulrich LG, Sørensen TI, Baker JL.

Int J Obes (Lond). 2016 Jul;40(7):1096-102. doi: 10.1038/ijo.2016.56. Epub 2016 Apr 28.

5.

Benign leiomyoma or malignant sarcoma: the difficult differential diagnosis.

Ulrich LG.

Maturitas. 2015 Mar;80(3):235-6. doi: 10.1016/j.maturitas.2014.12.021. Epub 2015 Jan 3. No abstract available.

PMID:
25604527
6.

Routine pelvic ultrasound before starting menopausal hormone therapy: should we do it?

Dreisler E, Ulrich LG.

Maturitas. 2014 Mar;77(3):197-8. doi: 10.1016/j.maturitas.2013.12.002. Epub 2013 Dec 18. No abstract available.

PMID:
24412577
7.

EMAS clinical guide: assessment of the endometrium in peri and postmenopausal women.

Dreisler E, Poulsen LG, Antonsen SL, Ceausu I, Depypere H, Erel CT, Lambrinoudaki I, Pérez-López FR, Simoncini T, Tremollieres F, Rees M, Ulrich LG; European Menopause and Andropause Society.

Maturitas. 2013 Jun;75(2):181-90. doi: 10.1016/j.maturitas.2013.03.011. Epub 2013 Apr 22.

PMID:
23619009
8.

Oophorectomy for whom and at what age? Primum non nocere.

Rocca WA, Ulrich LG.

Maturitas. 2012 Jan;71(1):1-2. doi: 10.1016/j.maturitas.2011.10.006. Epub 2011 Nov 12. No abstract available.

PMID:
22079872
9.

Endometrial safety of ultra-low-dose estradiol vaginal tablets.

Simon J, Nachtigall L, Ulrich LG, Eugster-Hausmann M, Gut R.

Obstet Gynecol. 2010 Oct;116(4):876-83. doi: 10.1097/AOG.0b013e3181f386bb.

PMID:
20859151
10.

Current controversies about combined hormone therapy and the relative risks to the breast and endometrium.

Ulrich LG.

Climacteric. 2004 Sep;7(3):229-37. No abstract available.

PMID:
15669547
11.

Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.

Wells M, Sturdee DW, Barlow DH, Ulrich LG, O'Brien K, Campbell MJ, Vessey MP, Bragg AJ.

BMJ. 2002 Aug 3;325(7358):239.

12.

The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy.

Sturdee DW, Ulrich LG, Barlow DH, Wells M, Campbell MJ, Vessey MP, Nielsen B, Anderson MC, Bragg AJ.

BJOG. 2000 Nov;107(11):1392-400. Erratum in: BJOG 2001 Mar;108(3):335.

13.

Combined versus sequential hormonal replacement therapy: a double-blind, placebo-controlled study on quality of life-related outcome measures.

Bech P, Munk-Jensen N, Obel EB, Ulrich LG, Eiken P, Nielsen SP.

Psychother Psychosom. 1998 Jul-Oct;67(4-5):259-65.

PMID:
9693354
14.

Quality of life and patient preference for sequential versus continuous combined HRT: the UK Kliofem multicenter study experience. UK Continuous Combined HRT Study Investigators.

Ulrich LG, Barlow DH, Sturdee DW, Wells M, Campbell MJ, Nielsen B, Bragg AJ, Vessey MP.

Int J Gynaecol Obstet. 1997 Oct;59 Suppl 1:S11-7.

PMID:
9386211
15.

[Hormone therapy in women treated for breast cancer].

Ulrich LG.

Ugeskr Laeger. 1996 Sep 30;158(40):5636-7. Danish. No abstract available.

PMID:
8966795
16.

Accumulated knowledge of Kliogest safety aspects.

Ulrich LG.

Br J Obstet Gynaecol. 1996 May;103 Suppl 13:99-102; discussion 102-3. Review. No abstract available.

PMID:
8624352
17.

Is the timing of withdrawal bleeding a guide to endometrial safety during sequential oestrogen-progestagen replacement therapy? UK Continuous Combined HRT Study Investigators.

Sturdee DW, Barlow DH, Ulrich LG, Wells M, Gydesen H, Campbell M, O'Brien K, Vessey M.

Lancet. 1994 Oct 8;344(8928):979-82. Erratum in: Lancet 1994 Nov 26;344(8935):1516.

PMID:
7934429
18.
19.

[Ultrasonic determination of the position of a coil when pregnancy has occurred].

Ulrich LG, Lynge P, Larsen J.

Ugeskr Laeger. 1987 Apr 13;149(16):1058-9. Danish. No abstract available.

PMID:
3554687
20.

[Acquired hypertrichosis lanuginosa. Review of the literature and a case report].

Ulrich LG, Munk-Jensen N.

Ugeskr Laeger. 1983 Aug 22;145(34):2586-7. Danish. No abstract available.

PMID:
6612885

Supplemental Content

Loading ...
Support Center